<?xml version='1.0' encoding='utf-8'?>
<document id="27006091"><sentence text="An evaluation of the CYP2D6 and CYP3A4 inhibition potential of metoprolol metabolites and their contribution to drug-drug and drug-herb interaction by LC-ESI/MS/MS."><entity charOffset="63-73" id="DDI-PubMed.27006091.s1.e0" text="metoprolol" /></sentence><sentence text="The aim of the present study was to evaluate the contribution of metabolites to drug-drug interaction and drug-herb interaction using the inhibition of CYP2D6 and CYP3A4 by metoprolol (MET) and its metabolites"><entity charOffset="173-183" id="DDI-PubMed.27006091.s2.e0" text="metoprolol" /></sentence><sentence text=" The peak concentrations of unbound plasma concentration of MET, α-hydroxy metoprolol (HM), O-desmethyl metoprolol (ODM) and N-desisopropyl metoprolol (DIM) were 90"><entity charOffset="60-63" id="DDI-PubMed.27006091.s3.e0" text="MET" /><entity charOffset="65-85" id="DDI-PubMed.27006091.s3.e1" text="α-hydroxy metoprolol" /><entity charOffset="87-89" id="DDI-PubMed.27006091.s3.e2" text="HM" /><entity charOffset="92-114" id="DDI-PubMed.27006091.s3.e3" text="O-desmethyl metoprolol" /><entity charOffset="116-119" id="DDI-PubMed.27006091.s3.e4" text="ODM" /><entity charOffset="125-150" id="DDI-PubMed.27006091.s3.e5" text="N-desisopropyl metoprolol" /><entity charOffset="152-155" id="DDI-PubMed.27006091.s3.e6" text="DIM" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e0" e2="DDI-PubMed.27006091.s3.e0" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e0" e2="DDI-PubMed.27006091.s3.e1" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e0" e2="DDI-PubMed.27006091.s3.e2" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e0" e2="DDI-PubMed.27006091.s3.e3" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e0" e2="DDI-PubMed.27006091.s3.e4" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e0" e2="DDI-PubMed.27006091.s3.e5" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e0" e2="DDI-PubMed.27006091.s3.e6" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e1" e2="DDI-PubMed.27006091.s3.e1" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e1" e2="DDI-PubMed.27006091.s3.e2" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e1" e2="DDI-PubMed.27006091.s3.e3" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e1" e2="DDI-PubMed.27006091.s3.e4" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e1" e2="DDI-PubMed.27006091.s3.e5" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e1" e2="DDI-PubMed.27006091.s3.e6" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e2" e2="DDI-PubMed.27006091.s3.e2" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e2" e2="DDI-PubMed.27006091.s3.e3" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e2" e2="DDI-PubMed.27006091.s3.e4" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e2" e2="DDI-PubMed.27006091.s3.e5" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e2" e2="DDI-PubMed.27006091.s3.e6" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e3" e2="DDI-PubMed.27006091.s3.e3" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e3" e2="DDI-PubMed.27006091.s3.e4" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e3" e2="DDI-PubMed.27006091.s3.e5" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e3" e2="DDI-PubMed.27006091.s3.e6" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e4" e2="DDI-PubMed.27006091.s3.e4" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e4" e2="DDI-PubMed.27006091.s3.e5" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e4" e2="DDI-PubMed.27006091.s3.e6" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e5" e2="DDI-PubMed.27006091.s3.e5" /><pair ddi="false" e1="DDI-PubMed.27006091.s3.e5" e2="DDI-PubMed.27006091.s3.e6" /></sentence><sentence text="37 ± 2" /><sentence text="69, 33" /><sentence text="32 ± 1" /><sentence text="92, 16" /><sentence text="93 ± 1" /><sentence text="70 and 7" /><sentence text="96 ± 0" /><sentence text="94 ng/mL, respectively" /><sentence text=" The metabolites identified, HM and ODM, had a ratio of metabolic area under the concentration-time curve (AUC) to parent AUC of ≥0"><entity charOffset="29-31" id="DDI-PubMed.27006091.s12.e0" text="HM" /><entity charOffset="36-38" id="DDI-PubMed.27006091.s12.e1" text="ODM" /><pair ddi="false" e1="DDI-PubMed.27006091.s12.e0" e2="DDI-PubMed.27006091.s12.e0" /><pair ddi="false" e1="DDI-PubMed.27006091.s12.e0" e2="DDI-PubMed.27006091.s12.e1" /></sentence><sentence text="25 when either total or unbound concentration of metabolite was considered" /><sentence text=" In vitro CYP2D6 and CYP3A4 inhibition by MET, HM and ODM study revealed that MET, HM and ODM were not inhibitors of CYP3A4-catalyzed midazolam metabolism and CYP2D6-catalyzed dextromethorphan metabolism"><entity charOffset="176-192" id="DDI-PubMed.27006091.s14.e0" text="dextromethorphan" /><entity charOffset="42-57" id="DDI-PubMed.27006091.s14.e1" text="MET" /><entity charOffset="78-93" id="DDI-PubMed.27006091.s14.e2" text="MET" /><entity charOffset="47-62" id="DDI-PubMed.27006091.s14.e3" text="HM" /><entity charOffset="83-98" id="DDI-PubMed.27006091.s14.e4" text="HM" /><entity charOffset="54-69" id="DDI-PubMed.27006091.s14.e5" text="ODM" /><entity charOffset="90-105" id="DDI-PubMed.27006091.s14.e6" text="ODM" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e1" e2="DDI-PubMed.27006091.s14.e1" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e1" e2="DDI-PubMed.27006091.s14.e3" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e1" e2="DDI-PubMed.27006091.s14.e5" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e1" e2="DDI-PubMed.27006091.s14.e2" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e1" e2="DDI-PubMed.27006091.s14.e4" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e1" e2="DDI-PubMed.27006091.s14.e6" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e1" e2="DDI-PubMed.27006091.s14.e0" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e3" e2="DDI-PubMed.27006091.s14.e3" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e3" e2="DDI-PubMed.27006091.s14.e5" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e3" e2="DDI-PubMed.27006091.s14.e2" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e3" e2="DDI-PubMed.27006091.s14.e4" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e3" e2="DDI-PubMed.27006091.s14.e6" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e3" e2="DDI-PubMed.27006091.s14.e0" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e5" e2="DDI-PubMed.27006091.s14.e5" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e5" e2="DDI-PubMed.27006091.s14.e2" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e5" e2="DDI-PubMed.27006091.s14.e4" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e5" e2="DDI-PubMed.27006091.s14.e6" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e5" e2="DDI-PubMed.27006091.s14.e0" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e2" e2="DDI-PubMed.27006091.s14.e2" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e2" e2="DDI-PubMed.27006091.s14.e4" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e2" e2="DDI-PubMed.27006091.s14.e6" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e2" e2="DDI-PubMed.27006091.s14.e0" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e4" e2="DDI-PubMed.27006091.s14.e4" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e4" e2="DDI-PubMed.27006091.s14.e6" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e4" e2="DDI-PubMed.27006091.s14.e0" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e6" e2="DDI-PubMed.27006091.s14.e6" /><pair ddi="false" e1="DDI-PubMed.27006091.s14.e6" e2="DDI-PubMed.27006091.s14.e0" /></sentence><sentence text=" However, DIM only met the criteria of &gt;10% of the total drug related material and &lt;25% of the parent using unbound concentrations"><entity charOffset="10-12" id="DDI-PubMed.27006091.s15.e0" text="DIM" /></sentence><sentence text=" If CYP inhibition testing is solely based on metabolite exposure, DIM metabolite would probably not be considered"><entity charOffset="67-69" id="DDI-PubMed.27006091.s16.e0" text="DIM" /></sentence><sentence text=" However, the present study has demonstrated that DIM contributes significantly to in vitro drug-drug interaction"><entity charOffset="50-52" id="DDI-PubMed.27006091.s17.e0" text="DIM" /></sentence><sentence text=" Copyright © 2016 John Wiley &amp; Sons, Ltd" /><sentence text=" " /></document>